Patents Assigned to Ascensia Diabetes Care Holdings AG
  • Patent number: 10921278
    Abstract: A biosensor system determines analyte concentration from analytic and/or secondary output signals. The biosensor system adjusts a correlation for determining analyte concentrations from output signals with one or more index functions extracted from the output signals. The index functions determine at least one slope deviation or normalized slope deviation from one or more error parameters. The slope-adjusted correlation between analyte concentrations and output signals may be used to determine analyte concentrations having improved accuracy and/or precision from output signals including components attributable to bias.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: February 16, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Dijia Huang, Huan-Ping Wu
  • Patent number: 10908112
    Abstract: A sensor system, device, and methods for determining the concentration of an analyte in a sample is described. Input signals including multiple duty cycles of sequential excitation pulses and relaxations are input to the sample. One or more signals output from the sample within 300 ms of the input of an excitation pulse may be correlated with the analyte concentration of the sample to improve the accuracy and/or precision of the analysis. Determining the analyte concentration of the sample from these rapidly measured output values may reduce analysis errors arising from the hematocrit effect, mediator background, and other error sources.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: February 2, 2021
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventor: Huan-Ping Wu
  • Patent number: 10897503
    Abstract: Embodiments of the present invention enable setup synchronization of an end user medical device such as a blood glucose meter. Some embodiments may include a controller including a memory; a transceiver operatively coupled to the controller; and a host computer interface operative to couple the controller to a host computer, wherein the memory is operative to store instructions executable on the controller. The instructions are adapted to cause the controller to scan for an advertising medical device using the transceiver, establish a communications connection with a medical device advertising for synchronization, and transmit synchronization data to a medical device once a communication connection has been estabilshed. Numerous other aspects are disclosed.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: January 19, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Igor Gofman, Christopher Dionisio
  • Patent number: 10895550
    Abstract: Biosensor systems including a measurement device and test sensors including at least three independently addressable electrodes, with at least two of the electrodes being substantially chemically isolated are disclosed. One or more working electrodes may be combined with two or more counter electrodes. The two or more counter electrodes may operate at different potentials to provide for multi-analyte electrochemical analysis. Analysis methods are provided to perform multi-analyte electrochemical analysis and test sensors are provided having resistance to chemical mixing between secondary analysis regions.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: January 19, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Weiping Zhong, Joseph E. Perry, Eric Maurer, Sung-Kwon Jung
  • Patent number: 10888254
    Abstract: Embodiments of the invention provide apparatus, systems, and methods wherein pre-event and post-event analyte concentration readings associated with an event are collected and processed to determine a numerical delta. The numerical delta may be displayed on a visual display to aid in a ready determination of the affect that the event (alone or in combination with medication and/or insulin dosages) had on the analyte concentration levels. Medication and/or insulin dosages may be displayed alongside the numerical delta to gauge immediate relationships between numerical delta, dosage, and/or an associated event. Apparatus and systems for calculating and displaying the numerical delta are described, as are other aspects.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 12, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: David A. Simmons, Jeffery S. Reynolds, Paul M. Ripley, Stanley A. Telson
  • Patent number: 10885766
    Abstract: A method for using a meter and a meter (10) adapted to determine an analyte concentration reading, the meter comprising a display (12) adapted to display information to a user of the meter, the display including information directed to a post-meal test-time alarm (22?) that is adapted to remind the user to obtain a post-meal analyte concentration reading, and at least one user input mechanism (15) adapted to allow the user to activate the post-meal test-time alarm.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: January 5, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Barry D. Power, Jeffrey A. Culver
  • Patent number: 10871483
    Abstract: A device and system for automatic handling of a sensor strip by a part of a meter that includes a sensor strip having a first section, a second section, and an intermediate section. The sensor strip includes at least a first opening about a first end thereof and a second opening about a second end thereof. A meter part includes a pair of pivoting catches configured to engage and grasp a sensor strip from a container containing a plurality of sensor strips. The sensor strip may thus be removed from a container for testing without need for manual handling of the strip by a user.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: December 22, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Steven C. Charlton
  • Patent number: 10866353
    Abstract: Embodiments provide systems, methods and apparatus for illuminating a portion of the face of a display lens proximate to and along one or more edges of the display lens. The display lens includes a transparent lens having four edges and a face surface. At least one edge includes an angle relative to the face surface configured to reflect light in the lens out of the face surface. Numerous other aspects are provided.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: December 15, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jennifer L. Gass, Eugene R. Prais
  • Patent number: 10845358
    Abstract: The cartridge comprises a housing, a plurality of test sensors, a mechanical mechanism, and a pusher assembly. The housing forms at least one opening therethrough. The plurality of test sensors is stacked in the housing. The plurality of test sensors is adapted to assist in testing at least one analyte. The mechanical mechanism is adapted to urge the plurality of test sensors in a first direction. One of the plurality of test sensors is positioned for extraction from the cartridge. The pusher assembly is adapted to push one of the plurality of test sensors from the cartridge. The pusher assembly includes a ferromagnetic material or a magnet.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: November 24, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jeffery S. Reynolds, John P. Creaven
  • Patent number: 10763681
    Abstract: A system and method is described for rapid charging and power management of a battery for a meter. A charger component is operably associated with the meter and is capable of executing a rapid charge algorithm for a rechargeable battery. The algorithm includes monitoring for a connection to an external power source and implementing a charging routine of a battery at a first charge rate and then at a second charge rate. The second charge rate is lower than the first charge rate. A temperature rise in the rechargeable battery due to the first charge rate has a negligible heat transfer effect on the fluid sample. The meter can also include a power switch for controlling current flow to a battery fuel gauge. The power switch is open when the meter enters into a sleep mode. The state of battery charge is determined after the meter exits the sleep mode.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: September 1, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Igor Gofman, Jun Chen
  • Patent number: 10753923
    Abstract: A test meter for analyzing a body fluid sample applied to a test strip includes an outer housing having an opening, an actuator, and a cartridge positioned adjacent the outer housing. The cartridge further includes a dispensing member connected to the actuator, a plurality of stacked test strips biased toward the dispensing member, and a cartridge outer housing that is adjacent at least a portion of the dispensing member. Each time the actuator is actuated, the dispensing member is rotated to cause movement of one test strip from the plurality of stacked test strips through the opening, and another test strip is biased toward the dispensing member.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: August 25, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene R. Prais, Michael A. Botta, Narasinha Parasnis, Serban Peteu, John Creaven, Simin Yao
  • Patent number: 10739350
    Abstract: A biosensor system determines analyte concentration from an output signal generated from a light-identifiable species or a redox reaction of the analyte. The biosensor system adjusts a correlation for determining analyte concentrations from output signals with one or more index functions extracted from the output signals. The index functions determine at least one slope deviation value, ?S, or normalized slope deviation from one or more error parameters. The slope-adjusted correlation between analyte concentrations and output signals may be used to determine analyte concentrations having improved accuracy and/or precision from output signals including components attributable to bias.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: August 11, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu
  • Patent number: 10724985
    Abstract: A biosensor has an underfill detection system that determines whether a sample of a biological fluid is large enough for an analysis of one or more analytes. The underfill detection system applies an excitation signal to the sample, which generates an output signal in response to the excitation signal. The underfill detection system switches the amplitude of the excitation signal. The transition of the excitation signal to a different amplitude changes the output signal when the sample is not large enough for an accurate and/or precise analysis. The underfill detection system measures and compares the output signal with one or more underfill thresholds to determine whether an underfill condition exists.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: July 28, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Christine D. Nelson
  • Patent number: 10712335
    Abstract: Sensor clip assemblies, sensor clips, analyte testing systems, and methods for making and using the same are disclosed. A sensor clip assembly is disclosed for storing and dispensing analyte testing sensors. The sensor clip assembly includes numerous test sensors arranged in a stack. Each test sensor is configured to assist in testing an analyte in a fluid sample. The sensor clip assembly also includes a skeletal frame with a top, a bottom, and numerous sides. The top, bottom and sides are interconnected to define an internal chamber within which is stored the stack of test sensors. At least one of the sides includes one or more elongated rails with structural gaps on opposing sides thereof. For some configurations, multiple sides of the skeletal frame comprise at least one or multiple elongated rails, each of which has structural gaps on opposing sides thereof and may be columnar in nature.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: July 14, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Jeffery S. Reynolds, Eugene R. Prais
  • Patent number: 10714212
    Abstract: A portable data-management system based on an analyte testing device which communicates wirelessly with a mobile device. The mobile device runs an application to manage and analyze data obtained by the analyte testing device. The mobile device may assist the user in displaying testing data, identifying patterns to assist healthy behavior or issue warnings based on the collected data. The mobile device may be connected to a network to store user health data for use by other parties.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: July 14, 2020
    Assignee: Ascensia Diabetes Care Holding AG
    Inventors: Jun Chen, Harris Lieber, Erik Nelson, Jeffery S. Reynolds, Kevin Curran, Aseem Mehta, Dawn Rountree
  • Patent number: 10696998
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: June 30, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Patent number: 10690614
    Abstract: A method of distinguishing a control solution from a sample in an electrochemical test sensor is performed. The method includes adding a control marker to the control solution. The control solution includes the control marker and analyte. The test sensor includes working and counter electrodes, and a reagent. A potential is applied to the test sensor to oxidize the control marker and the analyte. The resulting electrical current is measured. A potential is applied to the test sensor lower than the other potential in which the potential is sufficient to oxidize the analyte and not the control marker. The resulting electrical current is measured. Determining whether a control solution or a sample is present based on the measured electrical currents. To increase the measured current, a salt may be added to the control solution in an amount sufficient to increase the electrical current by at least 5% as compared to a control solution in the absence of a salt.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: June 23, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jing Lin, Fu Hsiung Tsai, Huan-Ping Wu, Nicole D. Ellis, Henry C. Arndt
  • Patent number: 10677748
    Abstract: An analyte meter to detect an analyte concentration level in a bio-fluid sample may be cleaned and disinfected with a cleaning liquid without harming electrical and internal meter components. In some embodiments, the analyte meter is washable and immersable and may include a sealed sensor connector, sealed battery connector, and possibly a sealed USB connector that may be subjected to a cleaning liquid without the liquid entering an internal chamber of the analyte meter and contacting internal electronic components. In some embodiments, a sealed display screen and sealed keypad are provided such that liquids are prevented from entering the internal chamber. Manufacturing methods and systems utilizing the analyte sensors are provided, as are numerous other aspects.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: June 9, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, David Huang, James A. Johnson, Igor Y. Gofman, Jun Chen
  • Patent number: 10670553
    Abstract: A sensor system, device, and methods for determining the concentration of an analyte in a sample is described. Gated voltammetric pulse sequences including multiple duty cycles of sequential excitations and relaxations may provide a shorter analysis time and/or improve the accuracy and/or precision of the analysis. The disclosed pulse sequences may reduce analysis errors arising from the hematocrit effect, variance in cap-gap volumes, non-steady-state conditions, mediator background, a single set of calibration constants, under-fill, and changes in the active ionizing agent content of the sensor strip.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: June 2, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu
  • Patent number: 10662264
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: May 26, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield